Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Rakuten Medical Sets Up Outposts in Netherlands, Taiwan
June 3, 2019
- Janssen Japan Files Erleada for Castration-Sensitive Prostate Cancer
June 3, 2019
- Additional OS Data to Be Added to Xospata’s US Label: Astellas
June 3, 2019
- Biogen to Leverage Aducanumab Learnings, Spinraza to Remain Foundation of SMA Care: Japan Chief
June 3, 2019
- Takeda Shareholders Pitch Claw-Back Clause, Urge Execs to Return Pay If Loss Incurred on Big Investment
May 31, 2019
- Novartis, Sumitomo Dainippon to Jointly Promote Equa, EquMet
May 31, 2019
- Teva Takeda Yakuhin Voluntary Recalls Menatetrenone Capsules
May 31, 2019
- Application for Mitsubishi Tanabe’s ALS Drug Pulled in EU
May 31, 2019
- Ono Files Opdivo for Second-Line Treatment of Esophageal Cancer
May 31, 2019
- Otsuka Shoots for Pharma Sales of 1.08 Trillion Yen in 2023
May 31, 2019
- Tokyo Court Dismisses Genentech’s Bid to Block Rituxan Biosimilar
May 30, 2019
- Japan Drug Firms’ Average Overseas Sales Ratio Nearly 50%, Offshore Biz Remains Way to Go as Home Market Falters: Tally
May 30, 2019
- Japan’s 1st ADA Deficiency Treatment Revcovi Now Available: Teijin Pharma
May 30, 2019
- Janssen Launches Simponi Autoinjector in Japan, Mitsubishi Tanabe in Charge of Distribution
May 30, 2019
- MSD/Bayer’s Rosuzet Now Available in Japan
May 29, 2019
- Takeda to Launch New Manufacturing Facility for Leuplin; Aims to Maintain Its 110 Billion Yen Sales
May 29, 2019
- Insulin/GLP-1 Receptor Agonist Combo Demonstrates Efficacy in Japan PIII: Sanofi
May 29, 2019
- NEC Ties Up with French Biotech to Develop Neoantigen Vaccines Using AI
May 28, 2019
- Ribomic Files Patent for Aptamer Therapeutic, Ends Licensing Pact with Otsuka
May 27, 2019
- Hisamitsu’s Hyperhidrosis Drug Hit Main Goal in Japan PII
May 27, 2019
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…